Validating Pharmacological Disruption of Protein–Protein Interactions by Acceptor Photobleaching FRET Imaging-Reference-Cited by-同舟云学术

Validating Pharmacological Disruption of Protein–Protein Interactions by Acceptor Photobleaching FRET Imaging

Published:2013 Issue: Volume: Page:165-178
ISSN:1064-3745
Container-title:Target Identification and Validation in Drug Discovery
language:
Short-container-title:

Author:

Roszik Janos,Tóth Gábor,Szöllősi János,Vereb György

Publisher

Humana Press

Link

http://link.springer.com/content/pdf/10.1007/978-1-62703-311-4_11

Reference29 articles.

1. Förster T (1946) Energiewanderung und fluoreszenz. Naturwissenschaften 6:166–175

2. Clegg RM (2002) FRET tells us about proximities, distances, orientations and dynamic properties. J Biotechnol 82:177–179

3. Jares-Erijman EA, Jovin TM (2006) Imaging molecular interactions in living cells by FRET microscopy. Curr Opin Chem Biol 10:409–416

4. Vogel SS, Thaler C, Koushik SV (2006) Fanciful FRET. Sci STKE. 331:re2.

5. Vereb G, Matkó J, Szöllősi J (2009) Cytometry of fluorescence resonance energy transfer. In: Darzynkiewicz Z, Robinson JP, Roederer M (eds) Essential cytometry methods. Elsevier, Oxford, pp 55–108

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disrupting EGFR–HER2 Transactivation by Pertuzumab in HER2-Positive Cancer: Quantitative Analysis Reveals EGFR Signal Input as Potential Predictor of Therapeutic Outcome;International Journal of Molecular Sciences;2024-05-29

2. Pathogenic Variants in USH1G/SANS Alter Protein Interaction with Pre-RNA Processing Factors PRPF6 and PRPF31 of the Spliceosome;International Journal of Molecular Sciences;2023-12-18

3. Dual fluorescent labeling of GLP-1R in live cells via enzymatic tagging and bioorthogonal chemistry;RSC Chemical Biology;2022

4. Assessment of SENP3-interacting proteins in hepatocytes treated with diethylnitrosamine by BioID assay;Acta Biochimica et Biophysica Sinica;2021-01-09

5. Förster Resonance Energy Transfer Based Biosensor for Targeting the hNTH1–YB1 Interface as a Potential Anticancer Drug Target;ACS Chemical Biology;2020-03-03